Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹17.22
-
Fund Started
14 Sep 2023
-
Fund Size
₹2030.81 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
1 Year
13.00%
-
3 Year
-
-
5 Year
-
-
Equity
98.22%
-
Cash
1.78%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.81% |
Divi's Laboratories Ltd. | 8.38% |
Glenmark Pharmaceuticals Ltd. | 6.62% |
Lupin Ltd. | 6.44% |
Max Healthcare Institute Ltd. | 6.36% |
Alkem Laboratories Ltd. | 6.21% |
Aster DM Healthcare Ltd. | 5.42% |
Ipca Laboratories Ltd. | 4.80% |
Anthem Biosciences Ltd. | 4.46% |
Fortis Healthcare Ltd. | 4.02% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-
